A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

November 30, 2015

Conditions
Metastatic Clear Cell Renal Carcinoma
Interventions
DRUG

AZD2014

AZD2014 vs Everolimus

DRUG

Everolimus

comparing PFS in patients treated with AZD2014 vs Everolimus

Trial Locations (9)

BH7 7DW

Royal Bournemouth Hospital, Bournemouth

BN2 5BE

Royal Sussex County Hospital, Brighton

CV2 2DX

University Hospitals Coventry & Warwickshire NHS Trust, Coventry

G12 0YN

Beatson West of Scotland Cancer Center, Glasgow

LS9 7TF

St. James' Hospital, Leeds

EC1A 6BE

Barts Health NHS Trust, London

NW3 2QG

Royal Free London Hospital, London

SO16 6YD

Southampton General Hospital, Southampton

SS0 0RY

Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea

Sponsors
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Cancer Research UK

OTHER

lead

Queen Mary University of London

OTHER